SAN DIEGO, March 10, 2014 /PRNewswire/ -- "Changing lives with every breath." That's the new tagline accompanying a refreshed ResMed (NYSE: RMD) brand that aligns ResMed's appearance in the marketplace with its global focus on innovation that benefits patients' lives.
ResMed's new logo includes an updated wordmark combined with a visually appealing "pulse" curve that shifts in color from bright blue to rich red, symbolizing the transition that deoxygenated blood makes to oxygenated blood with every breath, and every beat of the heart.
"Our purpose is to improve the lives of patients who use our solutions to treat sleep-disordered breathing, COPD, and other chronic diseases," said ResMed CEO Mick Farrell. "Throughout our 25-year history we've worked closely with medical communities to achieve that objective and demonstrate the clinical as well as economic benefits of our solutions.
"Worldwide shifts in healthcare dynamics have opened up important opportunities to further impact the well-being of millions of undiagnosed patients," Farrell said. "Our new brand speaks clearly to our partners—from physicians, to homecare providers, to patients—that ResMed is the industry leader because we are steadfastly focused on changing lives with every breath."
The new brand transition starts with ResMed's U.S. operations, and will roll out globally throughout the year. A key element will be a refreshed and user-friendly company website—ResMed.com—that helps people more easily find information to help them on their journey to better breathing.
"ResMed has been making a difference from the day we began pioneering sleep apnea treatment in 1989," said Farrell. "Our new brand will be front and center as we continue making a difference to patients, to physicians, and to healthcare systems. It's exciting and it's just the first step in what will be a landmark year for ResMed, with launches of game-changing products and solutions."
About ResMed:
ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, COPD, and other chronic diseases. We develop innovative products and solutions to improve the health and quality of life of those who suffer from these conditions, and we work to raise awareness of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com.
|
Contacts: |
|
|
For News Media |
For Investors |
|
Gretchen Griswold |
David Pendarvis |
|
Director, Global Corporate Communications |
Chief Administrative Officer and Global |
|
O: 858-836-6789 |
General Counsel |
|
[email protected] |
O: 858-836-5000 |
|
[email protected] |
|
Logo - http://photos.prnewswire.com/prnh/20140310/LA79234LOGO-a
Logo - http://photos.prnewswire.com/prnh/20140310/LA79234LOGO-b
SOURCE ResMed Inc.